Balance Sheet - Rapport Therapeutics, Inc. (RAPP)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total cash and short-term investments | 490.54 | 305.28 | 147.48 | 31.16 |
| Other current assets | 8.02 | 4.52 | 3.39 | 0.11 |
| Total current assets | 498.56 | 309.80 | 150.87 | 31.27 |
| Total non-current assets | 13.87 | 5.13 | 4.55 | 0.34 |
| Total assets | 512.43 | 314.93 | 155.42 | 31.60 |
| Total current liabilities | 19.05 | 8.77 | 8.80 | 1.66 |
| Total non-current liabilities | 8.73 | 0.74 | 172.25 | 10.44 |
| Total liabilities | 27.78 | 9.51 | 181.06 | 12.10 |
| Total stockholders' equity | 484.65 | 305.43 | -25.63 | 19.51 |
| Common shares outstanding | 47 | 21 | 18 | 20 |
Show Quarterly Balance Sheet
Balance Sheet - Rapport Therapeutics, Inc. (RAPP)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 476.78 | 490.54 | 513.03 | 260.45 | 285.38 | 305.28 | 320.66 | 336.14 | 193.24 | 147.48 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 0.06 | ||||||||||||
| Other current assets | 7.86 | 8.02 | 7.63 | 9.80 | 5.59 | 4.52 | 5.28 | 4.53 | 5.48 | 3.39 | |||
| Total current assets | 484.70 | 498.56 | 520.66 | 270.24 | 290.97 | 309.80 | 325.94 | 340.67 | 198.73 | 150.87 | |||
| Total non-current assets | 12.90 | 13.87 | 14.66 | 15.25 | 11.09 | 5.13 | 5.21 | 5.43 | 7.56 | 4.55 | |||
| Total assets | 497.60 | 512.43 | 535.32 | 285.50 | 302.05 | 314.93 | 331.14 | 346.10 | 206.29 | 155.42 | |||
| Total current liabilities | 17.90 | 19.05 | 14.32 | 11.88 | 9.38 | 8.77 | 7.10 | 8.10 | 9.89 | 8.80 | |||
| Total non-current liabilities | 8.19 | 8.73 | 9.39 | 10.10 | 6.83 | 0.74 | 0.93 | 1.12 | 236.04 | 172.25 | |||
| Total liabilities | 26.09 | 27.78 | 23.71 | 21.98 | 16.22 | 9.51 | 8.03 | 9.21 | 245.92 | 181.06 | |||
| Total stockholders' equity | 471.51 | 484.65 | 511.62 | 263.51 | 285.84 | 305.43 | 323.11 | 336.89 | -39.63 | -25.63 | |||
| Common shares outstanding | 47 | 47 | 38 | 35 | 19 | 19 | 19 | 20 | 19 | 18 | 19 | 20 | 19 |